Omzo vs He & She MD: Compounded GLP-1 Care Compared
Quick verdict: Omzo emphasizes clinician-guided access to personalized compounded semaglutide and tirzepatide with starting prices listed, while He & She MD bundles compounded GLP-1 medication with a coaching app and 1:1 clinician messaging and advertises lower introductory monthly rates. This comparison covers pricing approach, medication format and regulatory notes, bundled support, and shipping and eligibility details for Omzo vs He & She MD.
Explore Omzo clinician-guided plans
Primary differences in Omzo vs He & She MD
This comparison uses the available evidence to highlight the most distinctive differences: pricing structure and terms, whether medications are compounded or branded prescriptions, bundled coaching and clinician access, formats and medication options, and shipping or renewal disclosures.
1. Pricing structure and promotional terms
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279 as presented on its platform. He & She MD advertises semaglutide injections starting at $139/month and tirzepatide at $199/month as six-month introductory rates that renew higher. He & She MD specifically notes the intro rates apply to the first six months and that plans renew at a higher six-month price after that term. Omzo states starting prices but does not provide the same six-month promo detail in the captured evidence.
See He & She MD intro pricing and terms
2. Compounded medications and regulatory notes
Both providers offer compounded GLP-1 options in the captured evidence and include regulatory disclosures. Omzo explains its Compounded Medication Program is prepared by a state-licensed sterile compounding pharmacy and notes those compounded drugs are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. He & She MD similarly states medications included in its GLP-1 Program are produced in USP-compliant, state-regulated pharmacies but are not reviewed by the FDA for safety, efficacy, or quality. Both preserve the regulatory qualifier that compounded products have not been FDA-reviewed.
3. Bundled support, clinician access and formats
Omzo frames care as clinician-guided plans reviewed by licensed U.S. providers and notes providers make the final determination on prescriptions. He & She MD bundles medication with an app that includes 1:1 clinician messaging, GLP-1-specific coaching, and progress tracking at no extra cost according to the captured evidence. He & She MD also lists three medication formats: semaglutide injection, oral semaglutide, and tirzepatide injection. Omzo references clinician-guided plans and the possibility of prescriptions for branded medications but emphasizes its compounded medication program.
Check Omzo medication options and clinician review
4. Shipping, membership and enrollment details
He & She MD states free expedited shipping, no membership fee, and that no insurance is needed; its landing evidence highlights free expedited shipping on every order and that medications ship straight to the door. Omzo mentions fast, discreet delivery and that medication costs are included in fees collected by Omzo, with pharmacies paid by Omzo, while also noting users are responsible for filling branded prescriptions if prescribed. Both sources advise checking eligibility with a clinician; Omzo explicitly notes clinicians determine eligibility and that Omzo is not a medical practice and does not create a doctor patient relationship.
Side-by-side comparison table: Omzo vs He & She MD
| Criteria | Omzo | He & She MD |
|---|---|---|
| Starting price | Semaglutide starting at $179; Tirzepatide starting at $279 | Semaglutide from $139/month intro; Tirzepatide from $199/month intro |
| Pricing terms | Listed starting prices; fees collected include medication costs | Introductory six-month rates that renew at higher six-month prices |
| Medication type | Compounded semaglutide and tirzepatide; providers may prescribe branded meds | Compounded semaglutide injection, oral semaglutide, tirzepatide injection |
| Regulatory note | Compounded medications are not FDA-approved and not reviewed by FDA | Compounded medications not reviewed by FDA for safety, efficacy, or quality |
| Bundled support | Clinician-guided plans reviewed by licensed U.S. providers | Coaching app with 1:1 clinician messaging and progress tracking included |
| Shipping and fees | Fast, discreet delivery; Omzo pays the pharmacies for compounded meds | Free expedited shipping; no membership fee; no insurance needed |
How eligibility and prescriptions work
Both sources state medications require clinician review and that not all customers will qualify for a prescription. Omzo emphasizes clinical services are provided by third party networks of U.S.-licensed clinicians who determine eligibility and make the final determination as to whether to prescribe medication. He & She MD notes medications require consultation and prescription by a clinician through its platform and that not all customers will qualify.
Review Omzo eligibility and clinician process
Bottom line: Omzo vs He & She MD
Omzo centers on clinician-guided access to personalized compounded semaglutide and tirzepatide with listed starting prices and explicit clinician review, while He & She MD pairs compounded GLP-1 medication with a coaching app, 1:1 clinician messaging, and lower six-month introductory monthly rates that renew at higher prices. Both disclose that compounded medications are not FDA-approved and that clinician determination is required.
Choose Omzo if…
You want clinician-guided plans that reference starting prices for compounded semaglutide and tirzepatide and clear statements that providers make the final prescription decision.
Choose He & She MD if…
You prioritize a bundled coaching app with 1:1 clinician messaging and lower six-month introductory monthly pricing for compounded GLP-1 medication, understanding those rates renew higher after the initial six months.